Anand Desai, managing director of Anupam Rasayan, said “we are partnering with a leading Japanese multinational to add three new molecules to our portfolio. These three molecules will be used as advance intermediates for highly specialized polymers and liquid crystals. We will be the exclusive supplier for these molecules out of India and this is in line with our strategy of expansion in fluoropolymer and electronic segments, manufacturing high value molecules and going up the value chain with support of our customers.

This LOI demonstrates the increasing confidence of global MNCs in our technical capabilities and sustainable supply chain and further reaffirms our focus on Make in India.”

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.

The company's consolidated net profit rose 13.2% to Rs 42.91 crore on 43.8% jump in revenue from operations to Rs 382.75 crore in Q3 FY23 over Q3 FY22.